AD-IR10

1 study on AD-IR10 curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.

Bottom line: TitrateLab currently curates 1 dated study on AD-IR10. The source summaries below describe published research; they do not establish product quality, safety, or clinical suitability.

AD-IR10 studies and clinical research

2026-04-04 PubMed · preclinical animal · n preclinical

Egg White Peptide Heals Diabetic Wounds by Reprogramming Immune Cells

This research highlights AD-IR10 as a promising novel therapeutic agent for accelerating diabetic wound healing. Its unique mechanism of action, involving the reprogramming of macrophage metabolism via the Keap1/Nrf2/…

Research tools

Free, no account — handy when you're working with AD-IR10.

Reconstitution calculator Bac water, concentration & insulin-unit math Verify a COA Look up a report number against our corpus

TitrateLab PRO

Unlock the complete evidence trail

Pro members save studies and unlock the full evidence breakdown and vendor lab data.

Complete vendor lab histories
Every linked certificate on file
Batch-level purity and quantity detail
Thousands of community reviews

Buyer protection: Wrong or defective product? Report it within 7 days. We broker a refund or reship with the vendor.

$12 monthly or $33 lifetime

Create free account

TitrateLab

You must be 21 or older to enter.

TitrateLab provides research-use information on peptides for adults. Confirm your age to continue.

For research purposes only. Not for human consumption. By entering you agree to our Terms & Privacy.

AD-IR10 studies and clinical research

Egg White Peptide Heals Diabetic Wounds by Reprogramming Immune Cells

Research tools